Logo
DCA

Johnson & Johnson

sp500
JNJHealthcareDrug Manufacturers - General
222,89 $US
-0.28%
Dernier cours
222,89 $US
2026-06-02
Variation 24h
-0.28%
-0.62 USD
Volume
3,7 M
Titres échangés
Fiabilité des données
Forte
16212 points (64 ans)

Évolution du cours

Lancer une simulation avec cet actif

JNJ

Paramètres globaux

Données disponibles du 02/01/1962 au 02/06/2026

Analyse Fondamentale

New
CAGR (5y)
5.60%
Revenue Growth
Net Margin
28.46%
Profitability
ROE
32.87%
Return on Equity
Debt / EBITDA
1.17
Solvency
PEG Ratio
2.99
Valuation vs Growth
Rev. Growth (TTM)
9.90%
Current Trend

Historique PER (5 ans)

Historical PE
Average (21.4x)
Current: 26.3x
Focus technique
JNJ
Volatilité 30j
22.77%
Écart MA50
-3.92%
Écart MA200
4.96%
Écart ATH
-10.33%
Momentum 3M
-9.14%
Score de risque
N/A

Volatilité modérée. Momentum neutre.

À propos de Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Investir cet actif
Acheter via Saxo Banque
🏦Courtier régulé (AMF)
🌍Accès marchés globaux
📈Outils professionnels

Lien commercial. Investir comporte des risques.

Analyse Technique & Risque

Metrics Clés

CAGR11.33%
Volatilité22.77%
Max Drawdown-18.58%

Momentum : JNJ

Indicateur synthétique
PEURNEUTREAVIDITÉ
59
Greed

Analyse Risque

VaR (95%)-2.13%
Santé DCA
95/100

Historique récent (60 jours)

DateClôtureVolume
2026-06-02222,89 $US3 676 189
2026-06-01223,51 $US5 962 384
2026-05-29225,33 $US6 188 580
2026-05-28230,80 $US6 733 852
2026-05-27231,29 $US5 835 500
2026-05-26230,18 $US6 427 813
2026-05-22234,34 $US5 460 721
2026-05-21231,73 $US5 196 882
2026-05-20229,32 $US3 376 613
2026-05-19230,00 $US6 002 888
2026-05-18228,92 $US9 222 828
2026-05-15226,71 $US11 232 375
2026-05-14230,80 $US3 037 929
2026-05-13230,42 $US5 327 127
2026-05-12224,26 $US8 349 434
2026-05-11221,43 $US3 625 123
2026-05-08221,32 $US3 850 388
2026-05-07222,51 $US6 771 465
2026-05-06224,62 $US7 823 079
2026-05-05225,55 $US5 271 298
2026-05-04224,20 $US8 151 408
2026-05-01227,19 $US6 022 437
2026-04-30229,85 $US8 143 777
2026-04-29227,35 $US6 884 458
2026-04-28227,79 $US5 428 778
2026-04-27225,34 $US5 498 001
2026-04-24227,50 $US5 778 847
2026-04-23230,65 $US6 947 896
2026-04-22226,10 $US6 637 218
2026-04-21226,16 $US11 492 057
2026-04-20230,69 $US7 751 452
2026-04-17234,18 $US8 830 656
2026-04-16234,54 $US8 561 323
2026-04-15238,67 $US6 420 271
2026-04-14240,10 $US10 125 357
2026-04-13237,96 $US5 353 143
2026-04-10238,46 $US4 959 168
2026-04-09241,31 $US4 337 851
2026-04-08241,30 $US6 647 942
2026-04-07238,41 $US4 750 813
2026-04-06240,97 $US4 440 399
2026-04-02243,04 $US5 282 963
2026-04-01244,12 $US4 570 359
2026-03-31244,44 $US4 863 682
2026-03-30242,49 $US4 503 993
2026-03-27240,45 $US5 772 651
2026-03-26239,24 $US4 812 443
2026-03-25239,93 $US6 454 367
2026-03-24235,27 $US5 184 429
2026-03-23235,42 $US7 301 338
2026-03-20235,37 $US17 149 592
2026-03-19237,60 $US4 866 957
2026-03-18237,28 $US6 678 607
2026-03-17238,11 $US4 681 347
2026-03-16243,19 $US4 606 588
2026-03-13241,52 $US6 414 884
2026-03-12242,04 $US7 696 685
2026-03-11242,99 $US5 173 159
2026-03-10243,71 $US7 214 100
2026-03-09242,59 $US5 745 711

Derniers Dividendes

DateMontant
2026-02-24+1,30 $US
2025-11-25+1,30 $US
2025-08-26+1,30 $US
2025-05-27+1,30 $US
2025-02-18+1,24 $US
2024-11-26+1,24 $US
2024-08-27+1,24 $US
2024-05-20+1,24 $US
2024-02-16+1,19 $US
2023-11-20+1,19 $US
2023-08-25+1,19 $US
2023-05-22+1,19 $US
2023-02-17+1,13 $US
2022-11-21+1,13 $US
2022-08-22+1,13 $US
2022-05-23+1,13 $US
2022-02-18+1,06 $US
2021-11-22+1,06 $US
2021-08-23+1,06 $US
2021-05-24+1,06 $US

Actifs Relatifs